Osaic Holdings
EVLO

Osaic Holdings’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Osaic Holdings’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-75
Closed -$242 – 7699
2023
Q2 		$242 Hold
75
– – ﹤0.01% 7171
2023
Q1 		$326 Hold
75
– – ﹤0.01% 7201
2022
Q4 		$2K Buy
+75
New +$2.97K ﹤0.01% 6758
2022
Q1 		– Sell
-38
Closed -$5K – 7678
2021
Q4 		$5K Buy
+38
New +$6.42K ﹤0.01% 6685

Other funds holding EVLO

FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HP
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 40.24% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $99.1B AUM 124.46% 1-Year Est. Return

Osaic Holdings's EVLO Position: Q3 2023 in Review

Osaic Holdings sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q3 2023, closing a stake of 75 shares — an estimated $242 sold.

Osaic Holdings first reported a position in EVLO in Q4 2021 and held it in 4 quarters. The position peaked at $5K in Q4 2021. 29 funds tracked by Wall St. Rank hold EVLO as of Q3 2023.

  • Osaic Holdings reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Osaic Holdings sold 75 Evelo Biosciences, Inc. Common Stock shares in Q3 2023, an estimated $242.
  • Osaic Holdings first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2021 and held it in 4 quarters.
  • Osaic Holdings's Evelo Biosciences, Inc. Common Stock position peaked at $5K in Q4 2021.
  • 29 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q3 2023.

Based on Osaic Holdings's 13F filing for Q3 2023, filed 13 Nov 2023.